skip to page content

Greece, China And The Trade Triangles Have A Lot In Common

Adam Hewison - MarketClub

Loading the player...

It seems all we can talk about in the markets are the ongoing Greek charade or the next talking point China. You will hear no end of experts telling you what they think of Greece and China and what will happen if this or that takes place. The reality is, no one knows for sure what's going to happen. 

My advice, simplify, simplify, simplify. Keep it simple as the market doesn't pay you more for overthinking. In fact the market doesn't care what you or anyone else thinks, it's going to go its own way no matter what.

And that's the beauty of the Trade Triangle technology it doesn't over think the markets. In fact it doesn't think at all it's an algorithm. 
 
To the best of my knowledge, no one predicted the recent weakness in crude oil. As everyone knows usage tends to be high in the summer months when people travel for vacations. 

Remember I said no one knows, however, the Trade Triangle technology is an unbiased algorithm that literally goes with the flow and does not overthink any situation. You only have to look at a chart of crude oil to see just how this simple unbiased approach has performed. The Trade Triangles have made close to a 150% return in the last eight days based on latest Trade Triangle signal. That represents a gain of about $6,000 per contract in just over a week, and that's not listening to anyone except what the market is telling the algorithm!

So when it comes to investing and trading look no further than MarketClub's Trade Triangle technology as it will over time far outperform most of the so-called experts out there.

Today, I will be looking at two stocks that gave important buy signals yesterday. 

They are: 

Teva Pharmaceutical Industries Limited (NYSE:TEVA) with a buy signal @ $61.62.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers generic or branded generic medicines; specialized products, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances; and active pharmaceutical ingredients. 

Opko Health Inc. (NYSE:OPK) with a buy signal @ $16.59.

OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics. The company develops various solutions to diagnose, treat, and prevent various conditions, including point-of-care tests, molecular diagnostics tests, laboratory developed tests, and proprietary pharmaceuticals and vaccines.

Both of these stocks have many technical indicators besides the Trade Triangles in positive positions. For example, the RSI is the above 50 and the MACD has just crossed over from a low point for both TEVA and OPKO. I see both of these stocks moving higher.

In addition to TEVA and OPKO, I will be looking at all three major indices, crude oil and gold. I will also be taking a quick look at the euro in light of what's going on in Greece.

Back to videos

Get Started With Your 30-Day MarketClub Trial Right Now

Get Started

© Copyright MarketClub™ All rights reserved | User Agreement | Do Not Sell My Information

U.S. Government Required Disclaimer—Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41—HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

All trades, patterns, charts, systems, etc., discussed in this advertisement and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher or INO.com. No system or methodology has ever been developed that can guarantee profits or ensure freedom from losses. No representation or implication is being made that using the MarketClub™ methodology or system will generate profits or ensure freedom from losses. The testimonials and examples used herein are exceptional results, which do not apply to the average member, and are not intended to represent or guarantee that anyone will achieve the same or similar results. Each individual's success depends on his or her background, dedication, desire, and motivation.